secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIORA THERAPEUTICS, INC. (—)
CIK:        0001580063
Form:       8-K
Filed at:   2024-12-30T23:59:59+00:00
Accession:  0001213900-24-113256
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.03, 2.04, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biora Therapeutics files Chapter 11 bankruptcy, secures DIP financing up to $10.25M
--------------------------------------------------------------------------------

- Filed Chapter 11 on Dec 27, 2024; seeks sale of assets via court-supervised process.
- Secured up to $10.25M new DIP financing; total DIP commitment $46.125M (inc. roll-up).
- Lenders agreed to serve as stalking horse bidder; sale process milestones set for Q1 2025.
- Company warns equity holders face significant or complete loss on investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580063/000121390024113256/0001213900-24-113256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580063/000121390024113256/ea0226262-8k_biora.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-113256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer